Vinpocetine CAS#42971-09-5

Vinpocetine, with the CAS number 42971-09-5, is a synthetic compound derived from the alkaloid vincamine. It has gained significant attention in the field of medicine and healthcare due to its unique properties and potential therapeutic applications.

Vinpocetine is a white to off-white crystalline powder, The compound is sparingly soluble in water but shows good solubility in organic solvents such as ethanol and chloroform. Vinpocetine is stable under normal storage conditions.

The mechanism of action of vinpocetine is complex and involves multiple pathways. It primarily acts as a cerebral vasodilator, increasing blood flow to the brain. Vinpocetine also inhibits phosphodiesterase 1 (PDE1), which leads to an increase in cyclic adenosine monophosphate (cAMP) levels. This increase in cAMP has several effects, including the relaxation of smooth muscle cells in blood vessels and the enhancement of neuronal signaling. Additionally, vinpocetine has antioxidant properties and can scavenge free radicals, protecting cells from oxidative damage.

Vinpocetine has been studied for its potential to improve cognitive function. It may enhance memory, attention, and concentration by increasing blood flow to the brain and protecting neurons from damage. Some studies have shown that vinpocetine can improve cognitive performance in patients with age-related cognitive decline, mild cognitive impairment, and even Alzheimer's disease.

Vinpocetine has been used in the treatment of stroke patients to promote recovery. By increasing blood flow to the affected areas of the brain, it can help to reduce brain damage and improve neurological function. Vinpocetine may also have neuroprotective effects, reducing the risk of further damage and promoting the regeneration of damaged neurons.

There is some evidence to suggest that vinpocetine may be beneficial in the treatment of certain hearing and vision disorders. It may improve blood flow to the inner ear and retina, potentially reducing symptoms such as tinnitus (ringing in the ears) and age-related macular degeneration.

Vinpocetine has also been investigated for its potential use in the treatment of other conditions such as migraines, depression, and Parkinson's disease. However, more research is needed to determine its effectiveness in these areas.

The most common side effects of vinpocetine include headache, dizziness, nausea, and flushing. These side effects are usually mild and transient. In rare cases, more serious side effects such as allergic reactions, liver toxicity, and bleeding disorders have been reported.

Hot Tags: Vinpocetine CAS#42971-09-5, China Vinpocetine CAS#42971-09-5 manufacturers, suppliers, Veterinary raw materials, CAS 19524 06 2